Arch Therapeutics, Inc.
ARTHQ
$0.0001
$0.000.00%
OTC PK
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 30.00K | 26.40K | 205.90K | 222.70K | 86.50K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | 1.32M | 1.33M | 1.34M | 1.36M | 1.38M |
Prepaid Expenses | 40.80K | 177.20K | 272.80K | 362.90K | 90.50K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 1.39M | 1.53M | 1.81M | 1.95M | 1.56M |
|
|||||
Total Current Assets | 1.39M | 1.53M | 1.81M | 1.95M | 1.56M |
Net Property, Plant & Equipment | 3.00K | 3.40K | 3.90K | 4.60K | 700.00 |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 3.50K | 3.50K | 3.50K | 3.50K | 3.50K |
Total Assets | 1.40M | 1.54M | 1.82M | 1.96M | 1.56M |
|
|||||
Total Accounts Payable | 2.92M | 2.97M | 2.77M | 2.30M | 2.47M |
Total Accrued Expenses | 1.65M | 1.42M | 1.48M | 1.53M | 1.02M |
Short-term Debt | -- | 1.13M | 950.00K | -- | 740.00K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 9.39M | 6.90M | 6.19M | 5.63M | 5.35M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 13.96M | 12.42M | 11.40M | 9.47M | 9.58M |
|
|||||
Total Current Liabilities | 13.96M | 12.42M | 11.40M | 9.47M | 9.58M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | 1.13M | 950.00K | -- | 740.00K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 13.96M | 12.42M | 11.40M | 9.47M | 9.58M |
|
|||||
Common Stock & APIC | 60.03M | 55.33M | 55.16M | 54.55M | 51.58M |
Retained Earnings | -72.59M | -66.21M | -64.74M | -62.06M | -59.60M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -12.56M | -10.88M | -9.58M | -7.51M | -8.02M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -12.56M | -10.88M | -9.58M | -7.51M | -8.02M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -12.56M | -10.88M | -9.58M | -7.51M | -8.02M |
|